Leidos nabs $12.4M contract to support vaccine efficacy

Leidos has won a single-award $12.4 million contract to improve the efficacy of vaccine candidates for prevention of anthrax and West Nile virus.

Under the contract, awarded by the National Institute of Allergy and Infectious Diseases, Leidos will prepare and assess formulations of their lead immune boosting agent compound, the company said in a release.

In order to complete the work under the contract, Leidos assembled a team that includes the Infectious Disease Research Institute, the Hawaii Biotech Institute, Pfenex Inc., Duke University, Molecular Diagnostics Services, the IIT Research Institute Inc., and Colorado State University.

About the Author

Mark Hoover is a senior staff writer with Washington Technology. You can contact him at, or connect with him on Twitter at @mhooverWT.

Reader Comments

Please post your comments here. Comments are moderated, so they may not appear immediately after submitting. We will not post comments that we consider abusive or off-topic.

Please type the letters/numbers you see above

What is your e-mail address?

My e-mail address is:

Do you have a password?

Forgot your password? Click here


  • POWER TRAINING: How to engage your customers

    Don't miss our Aug. 2 Washington Technology Power Training session on Mastering Stakeholder Engagement, where you'll learned the critical skills you need to more fully connect with your customers and win more business. Read More


    In our latest Project 38 Podcast, editor Nick Wakeman interviews Tom Romeo, the leader of Maximus Federal about how it has zoomed up the 2019 Top 100. Read More

contracts DB

Washington Technology Daily

Sign up for our newsletter.

Terms and Privacy Policy consent

I agree to this site's Privacy Policy.